Back
Viking Therapeutics Stock Predictions
Sponsored
VKTX
Sponsored
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Buy
61
VKTX
Viking Therapeutics
Last Price:
74.28
Seasonality Move:
18.5%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.Viking Therapeutics Stock Forecast
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 150.3% based on the past 8 years of stock performance.
- Viking Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Viking Therapeutics Stock Undervalued?
The current Viking Therapeutics [VKTX] share price is $68.86. The Score for VKTX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal. - VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 150.3% based on the past 8 years of stock performance.
Viking Therapeutics Stock Rating
Buy
61
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics overpriced?
- Viking Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
8.28
Prediction Charts
Market Cap:
7.59B
Price in USD:
68.86
Volume:
3.51M
Beta:
1.50
Technical Analysis
SMA50:
67.27
SMA100:
44.14
SMA200:
28.41
52-Wk Change:
246.38%
Stock Predictions
-
Is Viking Therapeutics stock public?
Yes, Viking Therapeutics is a publicly traded company. -
What is the Viking Therapeutics stock quote today?
The Viking Therapeutics stock price is 68.86 USD today. -
How to buy Viking Therapeutics stock online?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-8 | 75.43 | 75.84 | 76.81 | 74.03 |
Apr-9 | 75.22 | 72.83 | 76.18 | 71.74 |
Apr-10 | 70.50 | 71.63 | 71.84 | 68.30 |
Apr-11 | 70.94 | 70.87 | 71.73 | 70.39 |
Apr-12 | 70.00 | 68.62 | 70.81 | 68.42 |
Apr-15 | 68.51 | 66.95 | 70.00 | 66.25 |
Apr-16 | 66.26 | 67.90 | 68.48 | 65.50 |
Apr-17 | 69.09 | 66.54 | 69.78 | 66.21 |
Apr-18 | 66.13 | 64.73 | 66.25 | 64.50 |
Apr-19 | 64.54 | 63.37 | 65.80 | 61.64 |
Apr-22 | 64.13 | 63.90 | 64.94 | 62.30 |
Apr-23 | 64.45 | 64.93 | 67.58 | 63.51 |
Apr-24 | 65.75 | 65.07 | 67.78 | 64.43 |
Apr-25 | 63.00 | 68.86 | 69.17 | 62.56 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.48 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.